JAK2 and nonpapillary renal cell carcinoma: Furthermore, we demonstrated that ISG15 controls proliferation, migration, invasion, apoptosis, and cell cycle progression in ccRCC via modulating the IL-6/JAK2/STAT3 signaling pathway (Fig. 6H).